Association between CYP11B2 rs1799998 genetic variant with essential hypertension and antihypertensive response.
文献摘要
Background Essential hypertension (EH) is influenced by genetic and environmental factors. The CYP11B2 gene, encoding aldosterone synthase, plays a major role in blood pressure regulation. This study investigated the association of the CYP11B2 -344C/T (rs1799998) variant with EH in Jordanians and evaluated its influence on response to amlodipine and valsartan. Methods A case-control study was conducted involving 309 Jordanian participants (154 hypertensive patients and 155 normotensive controls). Genotyping was performed using PCR-RFLP. Blood pressure (BP) was recorded before and after 1 month of treatment with either 80 mg valsartan or 10 mg amlodipine. Results Genotype frequencies (TT: 32.0%, TC: 50.5%, CC: 17.5%) and T allele frequency (57.28%) did not differ significantly between hypertensive and control groups ( p > 0.05). No association was found between rs1799998 and EH. Both valsartan and amlodipine significantly reduced BP ( p p = 0.028). Conclusion The CYP11B2 -344C/T variant was not associated with EH in Jordanians, but it was associated with amlodipine response. Further studies with larger sample size are needed to validate these findings.